ALEXANDER MARGARET A. (President and CEO) sold 15.9% of their position (11.66K shares) of OVID THERAPEUTICS INC. on the open market
Open‑market sale worth $16.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0002036798-26-000004
DirectorOfficer· President and CEO
Since Feb 2026
+1.42M
Net shares
Net buyer
$16.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.44M acquired · 11.66K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.66K
Price / share
$1.45
Trade value
$16.90K
% of position
15.9%
2/23/2026
73.41K→61.75K
Total
Net shares
−11.66K
Net value
-$16.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | S · Sale | −11.66K | $1.45 | $16.90K | 15.9% | 73.41K | 61.75K |
| Total | −11.66K | -$16.90K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.44M shares
Shares
+1.44M
Strike price
1.65
Held after
1.44M
Exercisable
—
2/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock1.44M shares | 2/26/2026 | A · Award | +1.44M | 1.65 | — | 1.44M |